The explosive was uncovered in the Sülz district of the west German city. "World War II bomb found in Sülz," the official account of the city of Cologne posted on X. "During construction work ...

2024 at 8:00 am EST to present topline results from COVALENT-111, the company’s Phase II trial of icovamenib in patients with type 2 diabetes. Conference Call and Webcast Details Webcast of ...

(“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent small molecules to ...

Analysis of the full Phase II COVALENT-111 data is ongoing and Biomea Fusion plans to present detailed results at an upcoming medical conference in 2025. "I am very excited about these initial ...

REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to ...

Overall, icovamenib was well tolerated and demonstrated a favorable safety profile in the COVALENT-111 study. The study will further assess secondary endpoints (e.g., HbA1c reduction, fasting glucose, ...

2024 at 8:00 am EST to present topline results from COVALENT-111, the company’s Phase II trial of icovamenib in patients with type 2 diabetes. Conference Call and Webcast Details Webcast of Biomea’s ...